Navigation Links
HealthSouth Reports Results for First Quarter Ended March 31, 2008
Date:5/6/2008

Revenues, Discharges, and Net Income Increase

Operating Cash Flows Increase

BIRMINGHAM, Ala., May 6 /PRNewswire-FirstCall/ -- HealthSouth Corporation (NYSE: HLS) (the "Company") today reported its results of operations for the first quarter ended March 31, 2008. Compared to the first quarter of 2007, net operating revenues increased by 5.8%, discharges increased by 2.7%, and net income increased by $76.4 million.

"The results of the first quarter indicate our growth strategies are gaining traction. Discharges were up 2.7% quarter over quarter and 5.3% sequentially, which drove net operating revenue increases of 5.8% and 6.8%, respectively. In addition to solid organic growth, the recent announcement of our purchase of The Rehabilitation Hospital of South Jersey demonstrates that our development efforts are starting to yield results," said Jay Grinney, President and Chief Executive Officer of HealthSouth. "In addition to implementing our growth strategies, we also continued to manage our expenses in a disciplined manner and, on March 31, 2008, closed on the sale of the corporate campus, which will yield additional expense reductions on a go-forward basis."

Net Operating Revenues

Consolidated net operating revenues for the first quarter of 2008 were $469.0 million, a $25.9 million, or 5.8% increase from the same quarter of 2007. Net operating revenues from our inpatient hospitals were $423.0 million, representing a 7.7% increase over the same quarter of 2007. This increase was primarily attributable to an increase in our Medicare reimbursement that was effective October 1, 2007 and a 2.7% increase in discharges quarter over quarter. The quarter-over-quarter increase in discharge
'/>"/>

SOURCE HealthSouth Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
2. HealthSouth Corporation Appoints New Member to Board of Directors
3. HealthSouth Announces Date of Third Quarter Earnings Conference Call
4. HealthSouth and Physicians Pay $14.9 Million to Settle Health Care Fraud Claims
5. HealthSouth Announces Final Agreement on Previously Disclosed Settlement with Federal Government
6. HealthSouth Issues Statement on Medicare Bill and 75% Rule
7. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
8. HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007
9. HealthSouth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference and the 2008 Credit Suisse Global Leveraged Finance Conference
10. HealthSouth Finalizes Sale of Corporate Campus to Daniel Corporation
11. HealthSouth Announces Date of 2008 First Quarter Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 3Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 4Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 5Ascension Orthopedics Hires Key Senior Executives 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Akorn Inc Announces Third Quarter 2009 Earnings Release and Conference Call Information 60113 1Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 1Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 2Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 3Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 4Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 5Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 6Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 7Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 8Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 9Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 10Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 11Medivation to Host Conference Call at 8 3A30 a m Eastern Time Tomorrow to Discuss Partnering Plans for MDV3100 14596 1